Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Antibacterial dose optimization in patients with febrile neutropenia: Are we targeting the right patients and the right endpoints?. Local targets link to admitted publications; unresolved targets remain external evidence.
Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data
10.1016/j.critrevonc.2017.11.005 · 2017 · External reference
Pharmacokinetic-pharmacodynamic modeling to evaluate the relative impact of immune response and meropenem on bacterial killing in vivo
10.1128/aac.01788-25 · 2026 · External reference
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
10.1093/annonc/mdw325 · 2016 · External reference
Australian PICNICC and There is No Place Like Home study groups. Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes
2024 · External reference
Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia
10.1128/aac.02561-14 · 2014 · External reference
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
2025 · External reference
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia
2025 · External reference
Club de Reflexion sur les Infections en Onco-Hématologie. Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia
10.1016/s1473-3099(08)70228-7 · 2008 · External reference
Prolonged vs short-term infusion of β-lactam antibiotics for the treatment of febrile neutropenia: A systematic review and meta-analysis
10.1016/j.jinf.2023.06.023 · 2023 · External reference
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial
10.1016/j.cmi.2024.10.006 · 2025 · External reference
BLING III Study Investigators. Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial
10.1001/jama.2024.9779 · 2024 · External reference
Antibiotic management of febrile neutropenia: current developments and future directions
10.1179/joc.2010.22.1.5 · 2010 · External reference
Management of fever in patients with cancer and treatment-induced neutropenia
10.1056/nejm199305063281808 · 1993 · External reference
Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country
10.1186/s12879-023-08058-6 · 2023 · External reference
Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial
10.1016/j.cmi.2016.11.001 · 2017 · External reference
Efficacy and safety of withholding antimicrobial therapy in children with cancer, fever, and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial
10.1016/j.cmi.2024.04.007 · 2024 · External reference
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia
2025 · External reference
Microbiological characterization of bacteremia in patients with chemotherapy-induced febrile neutropenia: systematic review and meta-analysis
2025 · External reference
10.3390/antibiotics10121485
10.3390/antibiotics10121485 · External reference
Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults
10.1007/s40262-024-01394-z · 2024 · External reference
In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis
10.1128/aac.02461-15 · 2015 · External reference
The importance of understanding the infectious microenvironment
10.1016/s1473-3099(21)00122-5 · 2022 · External reference
Infusional β-lactam antibiotics in febrile neutropenia: has the time come?
10.1097/qco.0b013e32835915c2 · 2012 · External reference
Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia
10.1128/aac.01253-25 · 2026 · External reference
Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii Pneumonia
10.1002/psp4.12312 · 2018 · External reference
Model-based assessment of neutrophil-mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies
10.1002/psp4.13046 · 2023 · External reference
Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models
10.1128/aac.01957-16 · 2016 · External reference
Impact of granulocytes on the antimicrobial effect of tedizolid in a mouse thigh infection model
10.1128/aac.00502-11 · 2011 · External reference
Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis
10.1186/s13054-024-04911-5 · 2024 · External reference
